Newsable Asianet News on MSN
GLP-1 drugs for diabetes: India details use, risks, and regulation
The Indian government has released details on GLP-1 drugs for diabetes and obesity, explaining their function and risks. Amid ...
Add Yahoo as a preferred source to see more of our stories on Google. The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating ...
The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new guidelines about glucagon-like peptide-1 (GLP-1) medications in the medical ...
Add Yahoo as a preferred source to see more of our stories on Google. In a move that could reshape how doctors approach both weight and heart health, the American College of Cardiology (ACC) released ...
The WHO recommended GLP-1s as a treatment for obesity alongside a healthy diet and regular exercise. Milles Team/Stocksy The World Health Organization (WHO) has recommended the use of GLP-1 ...
Hosted on MSN
New Guidelines on GLP-1 Drugs for Obesity Released
GLP-1 receptor agonists for obesity are effective over the long term when paired with lifestyle interventions, but global accessibility must be improved, the World Health Organization (WHO) concluded.
The Government of India has tightened regulation of GLP-1 drugs used for diabetes and weight loss, restricting prescriptions ...
A new World Health Organization (WHO) guideline recommending GLP-1s for obesity treatment along with recent efforts to reduce the drugs’ costs are unlikely to change US obesity practice — but actions ...
American Academy of Pediatrics guidelines that set off a new era in obesity treatment — and a national debate about whether children should be prescribed weight loss drugs — may have been shaped by ...
10don MSNOpinion
The Risk Too Many People Are Taking With Ozempic
It’s frustrating to watch, given my field of study.
The Drugs Controller General of India ramps up oversight on GLP-1 drugs, imposing strict penalties for violations concerning ...
The World Health Organization (WHO) has recommended the use of GLP-1 medications as part of treatment programs to help people manage obesity. In a new guideline published in JAMA, WHO officials said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results